Skip to main content
MarketStoryBook

CSL Limited in 1 story

The narratives CSL.AX currently appears in, with its side and exposure in each.

Bull side

0 stories

No bull-side stories for CSL.AX yet.

Bear side

1 story
  • America Imports the World's Drug Prices

    CSL.AX in “America Imports the World's Drug Prices”

    StableExposure: not rated yet

    US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.

    CSL's high-value plasma therapies and specialty biologics could face tougher US reimbursement ceilings when comparator-country prices are incorporated.